| Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30/04/2026 | ASSA ABLOY AB | stephanie ORDAN | Other senior executive | Acquisition | ASSA ABLOY AB ser. B | Share | SE0007100581 | 29/04/2026 | 16,690 | Quantity | 353.99 | SEK | Notification | ||
| 30/04/2026 | Evolution AB (publ) | Anna Kudrjavceva | Other senior executive | Acquisition | Warrants 2026/2029 serie I | Warrant | 24/04/2026 | 30,000 | Quantity | 18.80 | SEK | Notification | |||
| 30/04/2026 | Evolution AB (publ) | Anna Kudrjavceva | Other senior executive | Acquisition | Warrants 2026/2029 serie I | Warrant | 24/04/2026 | 60,000 | Quantity | 0.00 | SEK | Notification | |||
| 30/04/2026 | Rejlers AB (publ) | Jangunnar AB | Chairman of the Board of Directors | Acquisition | Rejlers AB ser. B | Share | SE0000123671 | 29/04/2026 | 6,702 | Quantity | 149.20 | SEK | Notification | ||
| 30/04/2026 | Expres2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | EXPRS2 UR | Subscription right/Unit right | SE0028501148 | 20/04/2026 | 56,588 | Quantity | 0.0102 | SEK | Notification | ||
| 30/04/2026 | Expres2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | EXPRS2 UR | Subscription right/Unit right | SE0028501148 | 20/04/2026 | 76,158 | Quantity | 0.0106 | SEK | Notification | ||
| 30/04/2026 | Expres2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | EXPRS2 UR | Subscription right/Unit right | SE0028501148 | 20/04/2026 | 121,230 | Quantity | 0.0102 | SEK | Notification | ||
| 30/04/2026 | Expres2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | EXPRS2 UR | Subscription right/Unit right | SE0028501148 | 20/04/2026 | 477 | Quantity | 0.011 | SEK | Notification | ||
| 30/04/2026 | Expres2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | EXPRS2 UR | Subscription right/Unit right | SE0028501148 | 20/04/2026 | 192,125 | Quantity | 0.0024 | SEK | Notification | ||
| 30/04/2026 | ASSA ABLOY AB | Allan David Talbot-cooper | Other senior executive | Acquisition | ASSA ABLOY B | Share | SE0007100581 | 29/04/2026 | 4,340 | Quantity | 353.99 | SEK | Notification |